U.S. flag

An official website of the United States government

NM_000384.3(APOB):c.10580G>A (p.Arg3527Gln) AND Cardiovascular phenotype

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 3, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002399330.9

Allele description [Variation Report for NM_000384.3(APOB):c.10580G>A (p.Arg3527Gln)]

NM_000384.3(APOB):c.10580G>A (p.Arg3527Gln)

Gene:
APOB:apolipoprotein B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p24.1
Genomic location:
Preferred name:
NM_000384.3(APOB):c.10580G>A (p.Arg3527Gln)
Other names:
R3500Q; 9775G>A
HGVS:
  • NC_000002.12:g.21006288C>T
  • NG_011793.1:g.42786G>A
  • NM_000384.3:c.10580G>AMANE SELECT
  • NP_000375.2:p.Arg3527Gln
  • NP_000375.3:p.Arg3527Gln
  • NC_000002.11:g.21229160C>T
  • NM_000384.2:c.10580G>A
  • NM_000384.3(APOB):c.10580G>AMANE SELECT
  • NP_000375.2:p.R3527Q
  • p.ARG3527GLN
Protein change:
R3527Q; Arg3500Gln
Links:
OMIM: 107730.0009
Molecular consequence:
  • NM_000384.3:c.10580G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002713792Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Pathogenic
(May 3, 2022) 		germlineclinical testing

PubMed (17)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.

Heath KE, Gudnason V, Humphries SE, Seed M.

Atherosclerosis. 1999 Mar;143(1):41-54.

PubMed [citation]
PMID:
10208479

Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in The Netherlands.

Lombardi MP, Redeker EJ, Defesche JC, Kamerling SW, Trip MD, Mannens MM, Havekes LM, Kastelein JJ.

Clin Genet. 2000 Feb;57(2):116-24.

PubMed [citation]
PMID:
10735632
See all PubMed Citations (17)

Details of each submission

From Ambry Genetics, SCV002713792.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (17)

Description

The p.R3527Q pathogenic mutation (also known as c.10580G>A), located in coding exon 26 of the APOB gene, results from a G to A substitution at nucleotide position 10580. The arginine at codon 3527 is replaced by glutamine, an amino acid with highly similar properties. This alteration (also reported as p.R3500Q) was initially reported in seven unrelated probands with familial hypercholesterolemia (FH) and found to segregate with disease in two families (Soria et al. Proc Natl Acad Sci USA. 1989; 86(2):587-91). This pathogenic mutation has been reported to be responsible for 2-6% of Western European FH cases and has been reported as an Amish founder mutation (Heath KE et al. Atherosclerosis. 1999;143(1):41-54; Lombardi et al. Clin Genet. 2000;57(2):116-24; Chmara M et al. J Appl Genet. 2010;51(1):95-106; Shen H et al. Arch Intern Med. 2010;170(20):1850-5). In addition, this alteration has been reported to result in defective low-density lipoprotein receptor binding (Boren J et al. J Clin Invest. 1998;101(5):1084-93). Two alterations at the same codon, p.R3527L and p.R3527W (reported as p.R3500L and p.R3500W), have also been associated with FH (Gaffney D et al. Arterioscler. Thromb. Vasc. Biol. 1995;15:1025-9; Fouchier SW et al. Hum. Mutat. 2005;26:550-6). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024